Given preservation of D and DA in the gastrointestinal lumen and portal vein system draining into the liver for first-pass metabolism (Fig. 2), they could have contributed directly to inhibit ROCK1/2 in these organs and their diseased conditions, such as liver steatohepatitis [87, 88] and IBD [69]. This evidence concerns the gene ROCK1 and inflammatory bowel disease.